Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access

How is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where can AI bridge gaps and solve challenges? What could this mean for the future of market access?In this webinar, Dr George Magrath explains how his team at Lexitas are using AI in clinical trials in the field of ophthalmology. George and Calum explore:- How, when and where AI is being used in clinical trials- How Lexitas are using AI in clinical trials for oph...